1-by-1 black pixel for creating lines
1-by-1 black pixel for creating lines
EricGiguere.com > Essays > Vioxx Is Prozac For Lawyers
Printer-friendly version Set your preferences
Read my blogs on AdSense and affiliate marketing
Learn about these ads

Vioxx Is Prozac For Lawyers

by Eric Giguere
October 22, 2004

The day after Merck announced it was voluntarily withdrawing Vioxx from the market (although it seems apparent that governments were going to force it off the market anyhow) I wrote a piece titled Vioxx Recall Leads To Worldwide Spam Reduction and put it up here on my site. It's a parody (I hope that was obvious!) and yet there are some grains of truth in it, because up to the day of the recall I was getting spam trying to sell me Vioxx. Other drugs, too, but Vioxx seemed to be one of the "top hitters". And I think it was something the spammers liked to push because it was definitely less offensive. I know Vioxx worked — I was actually taking it at the time for pain relief, though not for arthritis. So, like thousands (millions?) of others, I've been forced to look for something else.

Lawyers are the new Vioxx advertisers

In the piece, I talked about how the Vioxx recall could be a short-term windfall for Google and other ad publishers, because the lawyers would be looking for people who wanted to sue Merck. What I didn't know was how accurate that prediction would be!

I've been tracking the kind of ads that are being displayed via Google's AdSense program on Vioxx-related pages. It took almost no time for lawyers to step in and fill the gap left by online pharmacies who could no longer sell Vioxx. Sure, there are also ads for alternative pain relief treatments, but by and large the ads are predominantly from law firms looking for Vioxx-related business. You could say that Vioxx has become the new Prozac for lawyers... who needs a "feel happy" pill when you have such a juicy lawsuit target in your sights?

Vioxx withdrawal a disaster for Merck and others

The Vioxx recall is a marketing and a financial disaster for Merck. An article in today's Globe and Mail describes how the Vioxx fiasco drove down Merck's third-quarter profit by 29%. Things don't look good going forward, either. The article mentions how Merck faces "costly litigation" because of Vioxx. No surprise given all the lawyers jumping on the bandwagon.

Other drug companies may find themselves in similar positions. Drugs that are similar to Vioxx — the whole class of COX-2 inhibitors — are facing closer scrutiny as consumers and the medical profession wonder if they have the same long-term risks as Vioxx. I'm sure there are many excited lawyers looking into this, too!

Google Web www.ericgiguere.com   
1-by-1 black pixel for creating lines
Copyright ©2003-2012 Eric Giguere | Send mail about this page | About this site | Privacy policy
Site design and programming by Eric Giguere | Hosting by KGB Internet Solutions
This site is Java-powered
Other sites: The Unofficial AdSense Blog | Google Suggest Explorer | Invisible Fence Guide | Synclastic
This page was last modified on Last modified on October 22, 2004
1-by-1 black pixel for creating lines
1-by-1 black pixel for creating lines